EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended																12 Months Ended
		Jun. 30, 2020		Mar. 31, 2020		Dec. 31, 2019		Sep. 30, 2019		Jun. 30, 2019		Mar. 31, 2019		Dec. 31, 2018		Sep. 30, 2018		Jun. 30, 2020		Jun. 30, 2019		Jun. 30, 2018
Net Earnings																		$ 13,103		$ 3,966		$ 9,861
Net Earnings Attributable to Noncontrolling Interest																		76		69		111
Net Income (Loss) Attributable to Parent		$ 2,800		$ 2,917		$ 3,717		$ 3,593		$ (5,241)		$ 2,745		$ 3,194		$ 3,199		13,027	[1]	3,897	[1]	9,750	[1]
Dividends, Preferred Stock																		263		263		265
Net Income (Loss) Available to Common Stockholders, Basic																		12,764		3,634		9,485
Net Income (Loss) Available to Common Stockholders, Diluted																		$ 13,027		$ 3,634		$ 9,750
Weighted Average Number of Shares Outstanding, Basic																		2,487.1		2,503.6		2,529.3
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	[2]																	52.7		35.9		32.5
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock	[3]																	86.0		0.0		94.9
Weighted Average Number of Shares Outstanding, Diluted																		2,625.8		2,539.5		2,656.7
Earnings Per Share, Basic	[4],[5]																	$ 5.13		$ 1.45		$ 3.75
Earnings Per Share, Diluted		$ 1.07	[6]	$ 1.12	[6]	$ 1.41	[6]	$ 1.36	[6]	$ (2.12)	[6],[7]	$ 1.04	[6],[7]	$ 1.22	[6],[7]	$ 1.22	[6],[7]	$ 4.96	[4],[5],[6]	$ 1.43	[4],[5],[6],[7]	$ 3.67	[4],[5]

[1] Net earnings attributable to Procter & Gamble in fiscal 2019 was negatively impacted by the impairment charges of $8.3 billion related to Shave Care goodwill and Gillette indefinite-lived intangible assets.

[2] Weighted average outstanding stock options of approximately 6 million in 2020, 13 million in 2019 and 48 million in 2018 were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the assumed proceeds upon exercise would have exceeded the market value of the underlying common shares).

[3] Despite being included in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035. In fiscal year 2019, weighted average outstanding preferred shares of 90 million were not included in the Diluted net earnings per share calculation because to do so would have been antidilutive, due to lower Net earnings driven by the Shave Care impairment charges (see Note 4).

[4] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

[5] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

[6] Diluted net earnings/(loss) per share is calculated on Net earnings/(loss) attributable to Procter & Gamble.

[7] Diluted net earnings/(loss) per share in each quarter is computed using the weighted average number of shares outstanding during that quarter while Diluted net earnings/(loss) per share for the full year is computed using the weighted average number of shares outstanding during the year.  In the quarter ended June 30, 2019, the Company reported a Net loss attributable to P&G, driven by the Shave Care impairment charges discussed in Note 4.  This caused certain of our equity instruments to be antidilutive for the full year (preferred shares) and for the quarter ended June 30, 2019 (preferred shares and equity awards). Because these securities were dilutive during the first three quarters of this fiscal year, the sum of the four quarters' Diluted net earnings/(loss) per share will not equal the full-year Diluted net earnings per common share.